Company intelligence / Profile preview

Xishilan

Nanyang, Henan, China

Ownership: Private
Development stage: Other

Overview

Xishilan (Nanyang) Pharmaceutical is a prominent Chinese pharmaceutical company specializing in dermatological and personal care products. The company is best known for its flagship brand, Xishilan Xiaolu, a methenamine-based topical solution used to treat bromhidrosis (body odor) and hyperhidrosis. Established in Nanyang, Henan, Xishilan has maintained a dominant market share in the body odor treatment segment in China for decades. Its business model focuses on the production and distribution of over-the-counter (OTC) medications and health products. The company is listed on China's National Equities Exchange and Quotations (NEEQ).

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Xishilan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xishilan.

Explore the full profile